Related Experiment Video

Updated: Jun 22, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial

Karin Fjordén1, Sara Ekberg2, Nevzeta Kuric3

  • 1Department of Oncology, Lund University, Skane University Hospital, Lund, Sweden.

British Journal of Haematology
|August 26, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Idelalisibrelapsed/refractory DLBCLtransformed lymphoma

More Related Videos

Enhancing Tumor Content through Tumor Macrodissection10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Related Concept Videos